What is Inhibrx Biosciences, Inc.'s net change in cash?

Inhibrx Biosciences, Inc. (INBX) reported net change in cash of $37.44M in Q1 2026.

How has Inhibrx Biosciences, Inc.'s net change in cash changed year-over-year?

Inhibrx Biosciences, Inc.'s net change in cash decreased by 41.4% year-over-year, from $63.92M to $37.44M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Inhibrx Biosciences, Inc. INBX Net Change in Cash

Net Change in Cash at other companies

PfizerPFE

$563M+50.1%

Rogers CorporationROG

-$1.2M-108%

Merck & Co.MRK

-$9.29B-103%

Gilead SciencesGILD

$65M+103%

Nuvation BioNUVB

-$38.7M-416%

ArriVent BioPharma, Inc.AVBP

$16.56M+168%

Other financials

Income statement

See full

Revenue--100%

Operating income-$30.9M+27.9%

Net income-$33.4M+22.8%

EPS (diluted)-$2.15+23.2%

Balance sheet

See full

Cash & equivalents$161.7M-25.3%

Total debt$180.9M+69.8%

Total equity-$21.0M-122%

Total assets$184.0M-24.2%

Cash flow

See full

Operating cash flow-$38.0M-5.9%

CapEx--100%

Free cash flow-$38.0M-5.9%

Valuation

See full

Market cap$1.4B+546%

Enterprise value$1.42B+1,233%

P/S1,073.7×-280×

Profitability

See full

Operating margin-10,386.5%-5,025pp

Net margin-10,773.5%-878,492pp

FCF margin-9,986.5%-4,727pp

Returns & leverage

See full

Return on equity-197.8%-2,158pp

Debt / equity13.4×+13.3×

Current ratio6.5×+1.3×

Where this comes from

Reported directly by Inhibrx Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s net change in cash?: Inhibrx Biosciences, Inc. (INBX) reported net change in cash of $37.44M in Q1 2026.
How has Inhibrx Biosciences, Inc.'s net change in cash changed year-over-year?: Inhibrx Biosciences, Inc.'s net change in cash decreased by 41.4% year-over-year, from $63.92M to $37.44M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.